Introduction
Pocket Metab
Impressum
···
Diseases
···
Symptoms
···
Lab Parameters
···
Authors
···
Ramedis
···
BH4 Patient
Search by Referenz
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease
Ramsubir S,
Farber disease in a newborn
Sana C,
Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family
Devi AR,
Bone marrow involvement and obstructive jaundice in Farber lipogranulomatosis: clinical and autopsy report of a new case
Nowaczyk MJ,
Cerebrocostomandibular-like syndrome and a mutation in the conserved oligomeric Golgi complex, subunit 1
Zeevaert R
Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II
Foulquier F
Congenital glutamine deficiency with glutamine synthetase mutations
Kölker S
Golgi function and dysfunction in the first COG4-deficient CDG type II patient
Reynders E
COG8 deficiency causes new congenital disorder of glycosylation type IIh
Kranz C
A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation
Foulquier F
Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter
Martinez-Duncker I
Macrothrombocytopenia with abnormal demarcation membranes in megakaryocytes and neutropenia with a complete lack of sialyl-Lewis-X antigen in leukocytes--a new syndrome?
Willig TB
A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia
Morava E
Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder
Wu X
Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation
Etzioni A
Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in leukocyte adhesion deficiency type II (CDG IIc)
Sturla L
Notch deficiency implicated in the pathogenesis of congenital disorder of glycosylation IIc
Ishikawa HO
Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc
Yakubenia S
Dissociation profile of protonated fucosyl glycopeptides and quantitation of fucosylation levels of glycoproteins by mass spectrometry
Tajiri M
The Lec23 Chinese hamster ovary mutant is a sensitive host for detecting mutations in alpha-glucosidase I that give rise to congenital disorder of glycosylation IIb (CDG IIb)
Hong Y
Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II: a model for congenital disorder of glycosylation type IIa
Wang Y
A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis
Faid V
MGAT2 deficiency (CDG-IIa): The Life of J
de Cock P
Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient
Vleugels W
Congenital disorder of glycosylation (CDG) Ig: report on a patient and review of the literature
Di Rocco M
Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality
Kranz C
MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If
Schenk B
Congenital disorder of glycosylation (CDG) type Ie. A new patient
García-Silva MT
A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings
Dancourt J
CDG-Id in two siblings with partially different phenotypes
Kranz C
Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient
Rimella-Le-Huu A
Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient
Sun L
Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation
Eklund EA
Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology
Eklund EA
Novel ALG8 mutations expand the clinical spectrum of congenital disorder of glycosylation type Ih
Stölting T
A new case of ALG8 deficiency (CDG Ih)
Vesela K
Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms
Babovic-Vuksanovic D
Comparison between high performance liquid chromatography and capillary zone electrophoresis for the diagnosis of congenital disorders of glycosylation.
Quintana E
Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib
Liem YS
Development of liver disease despite mannose treatment in two patients with CDG-Ib
Mention K
Recurrent thrombo-embolism in a child with a congenital disorder of glycosylation (CDG) type Ib and treatment with mannose
Tamminga RY
The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib
de Lonlay P
RFT1 deficiency in three novel CDG patients
Vleugels W
Human RFT1 deficiency leads to a disorder of N-linked glycosylation
Haeuptle MA
Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects
Leroy JG
Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies
Lefeber DJ
Hypoglycosylation due to dolichol metabolism defects
Denecke J
A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy
Kranz C
Mono, di and tri-mannopyranosyl phosphates as mannose-1-phosphate prodrugs for potential CDG-Ia therapy
Hardré R
Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts
Higashidani A
Congenital disorders of glycosylation type Ia as a cause of mirror syndrome
Wurm D
Click zum Schliessen des Fensters